Live from the NIH registry
Studies recruiting near Rancho Cucamonga right now
Top 25 of 1,528 recruiting studies, sorted by proximity — each links to its official registry page
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Loma Linda University Medical Center (Adults only) — Loma Linda, California (18.3 mi)
· Sponsor: Pierre Fabre Medicament
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
NK-Cell Lymphoma, NK-Cell Leukemia
EARLY/Phase 1
Interventional 40 participants sought
Children's Hospital Orange County — Orange, California (28.5 mi)
· Sponsor: New York Medical College
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
City of Hope — Duarte, California (23.5 mi)
· Sponsor: Syndax Pharmaceuticals
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD) — Orange, California (28.5 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
Infant, Extremely Premature, Obstetric Labor, Premature
N/A
Observational 5,000 participants sought
Loma Linda University Children's Hospital — Loma Linda, California (18.3 mi)
· Sponsor: The University of Texas Health Science Center, Houston
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Loma Linda University Medical Center — Loma Linda, California (18.3 mi)
· Sponsor: National Cancer Institute (NCI)
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
Univ Cali Irvine ALS Neuromuscular — Orange, California (28.5 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
University of California, Irvine — Orange, California (28.5 mi)
· Sponsor: Lyell Immunopharma, Inc.
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Rheumatoid Arthritis, Systemic Lupus Erythematosus
Phase 1
Interventional 48 participants sought
Research Site — Fullerton, California (27.0 mi)
· Sponsor: AstraZeneca
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Loma Linda University Medical Center — Loma Linda, California (18.3 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Ovarian Cancer
Phase 1
Interventional 285 participants sought
City of Hope National Medical Center /ID# 281381 — Duarte, California (23.5 mi)
· Sponsor: AbbVie
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Multiple Myeloma
Phase 1
Interventional 127 participants sought
City of Hope National Medical Center /ID# 280273 — Duarte, California (23.5 mi)
· Sponsor: AbbVie
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Win Retina — Arcadia, California (26.8 mi)
· Sponsor: Boehringer Ingelheim
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma
Phase 1, Phase 2
Interventional 78 participants sought
City of Hope Medical Center — Duarte, California (23.5 mi)
· Sponsor: City of Hope Medical Center
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Carcinoma, Non-Small-Cell Lung
Phase 1, Phase 2
Interventional 450 participants sought
City of Hope ( Site 0014) — Duarte, California (23.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma
Phase 1
Interventional 694 participants sought
City of Hope National Medical Center /ID# 276272 — Duarte, California (23.5 mi)
· Sponsor: AbbVie
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Loma Linda University Medical Center — Loma Linda, California (18.3 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC
EGFR Mutant Advanced Non-small Cell Lung Cancer
Phase 1, Phase 2
Interventional 150 participants sought
Chao Family Comprehensive Cancer Center, University of California Irvine Healthcare — Orange, California (28.5 mi)
· Sponsor: J Ints Bio
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica Spectrum Disorder
Phase 2
Interventional 15 participants sought
Loma Linda University Children's Hospital - PIN — Loma Linda, California (18.3 mi)
· Sponsor: Amgen
Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
Necrotizing Soft Tissue Infection
N/A
Observational 50 participants sought
University of California Irvine Medical Center — Orange, California (28.5 mi)
· Sponsor: University of California, Irvine
A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors
Advanced Cancer, Solid Tumor
Phase 1
Interventional 26 participants sought
City of Hope National Medical Center — Duarte, California (23.5 mi)
· Sponsor: Proviva Therapeutics, Inc.
Study With [225Ac]Ac-FL-020 in mCRPC Participants
Metastatic Castration-resistant Prostate Cancer
Phase 1
Interventional 50 participants sought
City of Hope Medical Center — Duarte, California (23.5 mi)
· Sponsor: Full-Life Technologies UK Limited
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Oncura Health - Anaheim — Anaheim, California (28.2 mi)
· Sponsor: Pfizer
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Multiple conditions
Phase 1
Interventional 39 participants sought
City of Hope Comprehensive Cancer Center — Duarte, California (23.5 mi)
· Sponsor: National Cancer Institute (NCI)
Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas
Follicular Helper T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Not Otherwise Specified
Phase 2
Interventional 25 participants sought
City of Hope Medical Center — Duarte, California (23.5 mi)
· Sponsor: City of Hope Medical Center